相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Treatment patterns, outcomes and clinical characteristics in advanced renal cell carcinoma: a real-world US study
Jennifer P. Hall et al.
FUTURE ONCOLOGY (2020)
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme
Ugo De Giorgi et al.
BJU INTERNATIONAL (2019)
Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma
Brian I. Rini et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program
Elena Verzoni et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Real-world treatment patterns and adverse events in metastatic renal cell carcinoma from a large US claims database
Sumanta Pal et al.
BMC CANCER (2019)
Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group
Giuseppe Procopio et al.
FUTURE ONCOLOGY (2019)
Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised, phase 3 trial
David Cella et al.
LANCET ONCOLOGY (2019)
The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of advanced renal cell carcinoma (RCC)
Brian Rini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
Thomas Powles et al.
EUROPEAN UROLOGY (2018)
Quality of Life Outcomes for Cabozantinib Versus Everolimus in Patients With Metastatic Renal Cell Carcinoma: METEOR Phase III Randomized Trial
David Cella et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Adjuvant sunitinib in patients with high-risk renal cell carcinoma: safety, therapy management, and patient-reported outcomes in the S-TRAC trial
M. Staehler et al.
ANNALS OF ONCOLOGY (2018)
Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study
Nuria Lainez et al.
BMC CANCER (2016)
Evidence for validity of a national physician and patient-reported, cross-sectional survey in China and UK: the Disease Specific Programme
S. M. Babineaux et al.
BMJ OPEN (2016)
Trends in medication use in patients with type 2 diabetes mellitus: a long-term view of real-world treatment between 2000 and 2015
Victoria Higgins et al.
DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY (2016)
Pazopanib in the treatment of advanced renal cell carcinoma
David Cella et al.
THERAPEUTIC ADVANCES IN UROLOGY (2016)
Ongoing Screening and Treatment to Potentially Reduce Tyrosine Kinase Inhibitor-Related Fatigue in Renal Cell Carcinoma
Deepa Anand et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2015)
Patient-reported outcomes for axitinib vs sorafenib in metastatic renal cell carcinoma: phase III (AXIS) trial
D. Cella et al.
BRITISH JOURNAL OF CANCER (2013)
General population norms for the Functional Assessment of Cancer Therapy-Kidney Symptom Index (FKSI)
Zeeshan Butt et al.
CANCER (2013)
Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
Robert J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Beyond Traditional Outcomes: Improving Quality of Life in Patients with Renal Cell Carcinoma
David Cella
ONCOLOGIST (2011)
Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor-Targeted Agents: Results From a Large, Multicenter Study
Daniel Y. C. Heng et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
Kiran Gupta et al.
CANCER TREATMENT REVIEWS (2008)
Real-world physician and patient behaviour across countries: Disease-Specific Programmes - a means to understand
P. Anderson et al.
CURRENT MEDICAL RESEARCH AND OPINION (2008)
Development and validation of a scale to measure disease-related symptoms of kidney cancer
David Cella et al.
VALUE IN HEALTH (2007)
分享论文
